• CTP Solution (100 mM): Enabling Precision in mRNA-LNP Assay

  2026-07-23

  Explore how CTP Solution (100 mM) empowers high-fidelity mRNA-LNP workflows as a pure Cytidine-5'-triphosphate substrate. This article delivers an advanced, assay-focused perspective linking nucleotide quality to translational performance in modern RNA therapeutics.

• Palbociclib (PD0332991) Isethionate: Precision in Cancer Mod

  2026-07-23

  Palbociclib (PD0332991) Isethionate empowers researchers to dissect cell cycle dynamics and drug resistance in physiologically relevant cancer models. Its robust, selective CDK4/6 inhibition delivers reproducible G0/G1 arrest and apoptosis, transforming both traditional and next-generation assembloid workflows.

• Verteporfin (SKU A8327): Data-Driven Solutions for Cell Viab

  2026-07-22

  This article offers a scenario-driven, evidence-based exploration of Verteporfin (SKU A8327) for researchers addressing cell viability, apoptosis, and autophagy assays. It integrates quantitative findings and vendor comparisons to clarify why Verteporfin from APExBIO is a robust, reproducible choice for photodynamic therapy and mechanistic studies.

• 4-Methylumbelliferyl-β-D-Glucopyranoside: Precision Tools fo

  2026-07-22

  Explore how 4-Methylumbelliferyl-β-D-Glucopyranoside (4-MUG) sets new standards for quantitative β-glucosidase and β-glucocerebrosidase activity assays. This article reveals the mechanistic, methodological, and translational insights critical for lysosomal enzyme research, with a unique focus on assay optimization and the next generation of mRNA-based therapies.

• GRE Combination Inhibits Melanogenesis via CREB/MITF Pathway

  2026-07-21

  This study demonstrates that a combination of glabridin, resveratrol, and ellagic acid (GRE) powerfully suppresses melanin synthesis, oxidative stress, and inflammation in cellular models. GRE achieves this by downregulating the CREB/MITF signaling axis, providing mechanistic clarity and translational potential for pigmentation regulation research and anti-inflammatory peptide studies.

• SFRP1 Attenuates Oral Submucous Fibrosis via Wnt/β-Catenin I

  2026-07-21

  This study demonstrates that SFRP1 reduces neutrophil infiltration and suppresses Wnt/β-catenin pathway activity to alleviate oral submucous fibrosis (OSF) in a mouse model. These findings clarify key mechanisms underlying OSF and highlight Wnt pathway modulation as a promising research direction for fibrotic disease intervention.

• Standardized Whole-Blood Assays Reveal Immunometabolic Contr

  2026-07-20

  This protocol paper introduces a standardized method for analyzing immune responses in human whole blood under defined metabolic modulation. By integrating selective metabolic inhibitors, the study enables precise dissection of how cellular metabolism shapes cytokine production, advancing immunometabolism research and cohort-based immune profiling.

• miR-660 in Macrophage EVs Drives Breast Cancer Metastasis vi

  2026-07-20

  This study reveals that tumor-associated macrophage-derived extracellular vesicles (EVs) deliver microRNA-660 (miR-660) to breast cancer cells, suppressing KLHL21 and activating the IKKβ/NF-κB p65 pathway, thereby promoting invasion and metastasis. These findings clarify a critical paracrine mechanism in the tumor microenvironment and highlight new avenues for metastasis-targeted interventions.

• CasKAS: Fast Genome-Wide Profiling of CRISPR Specificity via

  2026-07-19

  Marinov et al. introduce CasKAS, a rapid and cost-effective assay for mapping dCas9 and Cas9 binding specificity genome-wide by detecting single-stranded DNA formed during CRISPR binding. This approach streamlines off-target analysis, enabling both in vitro and in vivo applications, and offers a practical advance over complex or expensive prior methods.

• Naloxone Hydrochloride in Research: Beyond Antagonism to Ste

  2026-07-18

  Discover the multifaceted research potential of Naloxone hydrochloride as a potent opioid receptor antagonist. This article uniquely explores its emerging role in neural stem cell proliferation, immune modulation, and the nuanced assay decisions that elevate opioid receptor research.

• GLP-1 (9-36) amide: Precision Tools for GLP-1R Antagonism

  2026-07-17

  GLP-1 (9-36) amide empowers researchers to dissect GLP-1 receptor signaling with unmatched specificity in metabolic and diabetes studies. This guide delivers evidence-based protocols, troubleshooting tips, and practical insight for leveraging this peptide antagonist in complex experimental settings.

• Naloxone Hydrochloride: Applied Workflows for Opioid Researc

  2026-07-17

  Naloxone hydrochloride is more than a benchmark opioid receptor antagonist—it empowers neuroscientists, behavioral researchers, and immunologists to dissect opioid signaling and neural stem cell dynamics with reproducibility. Discover how APExBIO’s high-purity formulation supports robust experimental designs, troubleshooting, and innovative protocol enhancements across diverse biomedical domains.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Interactio

  2026-07-16

  This study demonstrates that naturally occurring angiotensin peptides, including Angiotensin 1/2 (1-6), significantly enhance binding of the SARS-CoV-2 spike protein to the AXL receptor, a key entry pathway in cells with low ACE2 expression. These findings illuminate new cross-domain interactions between the renin-angiotensin system and viral pathogenesis, with practical implications for both cardiovascular and infectious disease research.

• a-MSH, amide: Mechanistic Leverage for Translational Pigment

  2026-07-16

  This thought-leadership article deciphers the mechanistic and strategic value of a-MSH, amide for translational researchers in pigmentation and inflammation. We map its role in melanocortin signaling, anchor experimental insights from recent GRE pathway studies, and provide actionable guidance for leveraging APExBIO’s synthetic peptide in advanced research. By integrating cross-study findings and workflow recommendations, this article advances the translational conversation beyond standard product content.

• Ceramide-Driven Autophagy Fuels Fish Nodavirus Replication

  2026-07-15

  This study uses global lipidomics to reveal that ceramide accumulation is a critical pro-viral mechanism during red-spotted grouper nervous necrosis virus (RGNNV) infection. By delineating the metabolic and molecular interplay between ceramide synthesis and autophagy, the work identifies new intervention points for antiviral strategies in aquaculture.

15602 records 1/1041 page Next 12345 下5页 Last page